Toxicity manifesting as cosmetic hair alterations during erlotinib treatment.
Kudo
Kenichiro
K
Fujiwara
Keiichi
K
Tsushima
Mizuho
M
Mizuta
Makoto
M
Matsuo
Kiyoshi
K
Yonei
Toshiro
T
Sato
Toshio
T
D000230:Adenocarcinoma / Q000188:drug therapy*; D000369:Aged, 80 and over; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D018450:Disease Progression; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride